Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin Berger

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2015
Efficient Utilization of IgG for Antibody Replacement TherapyMelvin Berger
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Adverse effects of IgG therapyMelvin Berger
Clinical Immunology (Orlando, Fla.)|June 23, 2004
Subcutaneous immunoglobulin replacement in primary immunodeficienciesMelvin Berger
Allergy and Asthma Proceedings|March 16, 2002
Inflammatory mediators in cystic fibrosis lung diseaseMelvin Berger
Current Allergy and Asthma Reports|August 8, 2002
A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodiesMelvin Berger
Immunology and Allergy Clinics of North America|October 23, 2008
Subcutaneous administration of IgGMelvin Berger
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Intramuscular versus intravenous immunoglobulin replacement therapy and measurement of immunoglobulin levels during immunoglobulin replacement therapyPhillip Lieberman, Melvin Berger
Allergy and Asthma Proceedings|March 16, 2002
Intravenous gamma-globulin therapy in bronchial asthmaHoward J Schwartz, Melvin Berger
Journal of Clinical Immunology|May 28, 2004
Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseasesMelvin Berger, Paul J Pinciaro,
Autoimmunity Reviews|August 6, 2017
Role of anti-receptor autoantibodies in pathophysiology of sclerodermaMelvin Berger, Virginia D Steen
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2015
Efficient Utilization of IgG for Antibody Replacement TherapyMelvin Berger
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Adverse effects of IgG therapyMelvin Berger
Clinical Immunology (Orlando, Fla.)|June 23, 2004
Subcutaneous immunoglobulin replacement in primary immunodeficienciesMelvin Berger
Allergy and Asthma Proceedings|March 16, 2002
Inflammatory mediators in cystic fibrosis lung diseaseMelvin Berger
Current Allergy and Asthma Reports|August 8, 2002
A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodiesMelvin Berger
Immunology and Allergy Clinics of North America|October 23, 2008
Subcutaneous administration of IgGMelvin Berger
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Intramuscular versus intravenous immunoglobulin replacement therapy and measurement of immunoglobulin levels during immunoglobulin replacement therapyPhillip Lieberman, Melvin Berger
Allergy and Asthma Proceedings|March 16, 2002
Intravenous gamma-globulin therapy in bronchial asthmaHoward J Schwartz, Melvin Berger
Journal of Clinical Immunology|May 28, 2004
Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseasesMelvin Berger, Paul J Pinciaro,
Autoimmunity Reviews|August 6, 2017
Role of anti-receptor autoantibodies in pathophysiology of sclerodermaMelvin Berger, Virginia D Steen
Pageof 7